Basement membrane remodeling biomarkers are modulated and reflect treatment response to JAK inhibitors in patients with atopic dermatitis - results from two longitudinal clinical studies.
Nørgaard Have MK, Port H, Frølunde AS, Skovsgård CH, Larsen FS, Nielsen SH, Deleuran M, Vestergaard C
Journal of Investigative DermatologyIn the feed 18 Aug 2026, published online 18 Aug 2026, issue 2026 Aug 18, added to PubMed 18 Aug 2026
Topics: Atopic dermatitis & eczemaJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42612788 · DOI 10.1016/j.jid.2026.08.001